Comprehensive Management of Polycystic Ovary Syndrome: The Role of Metformin in Addressing Metabolic and Endocrine Dysregulation

Comprehensive Management of Polycystic Ovary Syndrome: The Role of Metformin in Addressing Metabolic and Endocrine Dysregulation

Background: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine and metabolic disorder that affects women of reproductive age, characterized by hormonal imbalances, insulin resistance, and a range of clinical manifestations, including infertility and metabolic disturbances. Effective manageme...

Full description

Saved in:

Bibliographic Details
Main Authors:	Martyna Kaźmierczak, Jakub Parys, Agnieszka Mikosińska, Patrycja Kałuziak, Marta Jajaczak, Maciej Mossakowski, Aleksandra Witek, Mateusz Litwin, Stanisław Jesionek
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2025-01-01
Series:	Journal of Education, Health and Sport
Subjects:	Polycystic Ovary Syndrome (PCOS) insulin resistance hyperandrogenism Rotterdam criteria metformin lifestyle interventions
Online Access:	https://apcz.umk.pl/JEHS/article/view/57421
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Metformin dosage and galectin-3 levels: insights from PCOS patients preparing for IVF
by: Valentina N. Nikolić, et al.
Published: (2025-01-01)

Effects Of Metformin And Myo-Inositol In Combination Versus Metformin As Monotherapy On The Metabolic Profile Of Polycystic Ovarian Syndrome Patients With Infertility
by: Hira Ehsan Khattak, et al.
Published: (2024-09-01)

Treatment with Metformin Can Improve Insulin Resistance and Lipid Profile in Non-Diabetic Iraqi Women with Polycystic Ovary Syndrome
by: Ali M. Kadim Al-Tuma, et al.
Published: (2024-10-01)

Comparing Assisted Reproductive Outcomes in Women with Different Polycystic Ovary Syndrome Phenotypes Undergoing Frozen Embryo Transfer
by: Anubhuti Patel, et al.
Published: (2023-10-01)

Delving into the therapeutic prospects of desmostachya bipinnata (L.) in the context of polycystic ovary syndrome (PCOS): A comprehensive review
by: Sarthak Mishra, et al.
Published: (2025-02-01)

Effects of non-pharmacological interventions on biochemical hyperandrogenism in women with polycystic ovary syndrome: a systematic review and network meta-analysis
by: Qi Jin, et al.
Published: (2025-01-01)

Quality of Life in The Community of Women with Polycystic Ovary Syndrome (PCOS): A Phenomenology Study
by: Neina Qonita Istiqomah, et al.
Published: (2023-12-01)

Treatment of chronic hepatitis B: options, monitoring, special cases and adverse effects
by: Mateusz Litwin Litwin, et al.
Published: (2025-01-01)

Hormonal contraception in women with polycystic ovary syndrome: Contraceptive and non-contraceptive effects. A clinical lecture
by: Olga A. Pustotina
Published: (2024-12-01)

Review of Urinary Tract Infections in Pregnancy: Risks, Complications and Management
by: Patrycja Kałuziak, et al.
Published: (2025-01-01)

Therapeutic potential of bisphosphonates - review of medical indications, mechanism of action, interactions and adverse effects
by: Agnieszka Mikosińska, et al.
Published: (2025-01-01)

An Overview of the Deadly Effects of Anabolic-Androgenic Steroids: Clinical Cases and Scientific Insights
by: Maciej Mossakowski, et al.
Published: (2025-01-01)

Snus and Health: A Review of the Literature on the Impact of Swedish Smokeless Tobacco on the Human Body
by: Marta Jajczak, et al.
Published: (2025-01-01)

Pityriasis versicolor: insight into current knowledge and treatment possibilities
by: Jakub Parys, et al.
Published: (2025-01-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome
by: Armaiti Parvez Mody, et al.
Published: (2025-01-01)

Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers
by: Xiufen Zheng, et al.
Published: (2025-01-01)

The influence of hepatocyte growth factor on the proliferation and differentiation of stem cells
by: Rafał Bieś, et al.
Published: (2025-01-01)

Vitiligo Review: etiopathogenesis, diagnosis and treatment
by: Aleksandra Witek, et al.
Published: (2025-01-01)

Infertility and Social Issue Have the Most Significant Impact on Health-Related Quality of Life Among Polycystic Ovarian Syndrome Women in South India
by: L. Hariprasath, et al.
Published: (2023-01-01)

Clomiphene Citrate versus Clomiphene Citrate in combination with other drugs in Ovulation Induction in Patients with Polycystic Ovary Syndrome
by: Mostafa Khodary, et al.
Published: (2025-07-01)

Impact of alcoholic extract from sea cucumber (Holothuria parva) on letrozole–induced polycystic ovary syndrome in adult female rats
by: Samaneh Askari, et al.
Published: (2024-12-01)

Clinical Pregnancy and Miscarriage Rates in relation to Vitamin D Supplementation among women with Hyper Androgenic PCOS: A prospective study
by: Sherif Sobhy Menshawy Khalifa, et al.
Published: (2025-01-01)

Functional Tests and Surveys Used to Assess Nervous System Dysfunction in Patients with Fabry Disease – A Review
by: Stanislaw Jesionek, et al.
Published: (2025-01-01)

Hotspots and research trends of gut microbiome in polycystic ovary syndrome: a bibliometric analysis (2012–2023)
by: Ruishan Wu, et al.
Published: (2025-01-01)

Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
by: Paola Quaresima, et al.
Published: (2025-01-01)

Prevalence and factors associated with non-alcoholic fatty liver disease among women with polycystic ovary syndrome
by: Maria Elisa Franciscatto, et al.
Published: (2025-01-01)

Serum microRNAs as Diagnostic Markers in Polycystic Ovary Syndrome: A Narrative Review
by: K Lavanya, et al.
Published: (2025-01-01)

Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets
by: Xuedan Lai, et al.
Published: (2025-02-01)

Digital Twin Technology in Resolving Polycystic Ovary Syndrome and Improving Metabolic Health: A Comprehensive Case Study
by: Paramesh Shamanna, MD, et al.
Published: (2025-01-01)

Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01)

Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome
by: Mina Amiri, et al.
Published: (2025-02-01)

Effect of metformin on the level of aqueous humor inflammatory cytokines in patients with cataract
by: Jiaxi Li, et al.
Published: (2025-01-01)

Relationship between body mass index and quality of life, use of dietary and physical activity self-management strategies, and mental health in individuals with polycystic ovary syndrome
by: Masters Melissa, et al.
Published: (2025-01-01)

GnRH pulse generator activity in mouse models of polycystic ovary syndrome
by: Ziyue Zhou, et al.
Published: (2025-01-01)

Ayurvedic Approaches to Holistic Management of Polycystic Ovary Syndrome (PCOS)
by: Ashvini D. Pardhekar, et al.
Published: (2024-12-01)

The association between melatonin hormone and reproductive hormones in polycystic ovary syndrome: A case–control study
by: Ban Jabir Edan, et al.
Published: (2024-01-01)

Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
by: Vakkas Korkmaz, et al.
Published: (2013-08-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01)

Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome
by: Eva Drnovsek, et al.
Published: (2022-06-01)